NCT02139618View on ClinicalTrials.gov

Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Facial Photodamage
Interventions
DRUG

Methyl Aminolevulinate (MAL)

DRUG

Placebo

Trial Locations (1)

01

IPS Universitaria, Medellín

All Listed Sponsors
collaborator

Grupo de Investigacion Dermatologica (GRID)

UNKNOWN

collaborator

IPS Universitaria-Universidad de Antioquia

UNKNOWN

lead

Fundación Dermabase

OTHER

NCT02139618 - Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage | Biotech Hunter | Biotech Hunter